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Abstract: A rapid, simple to use and low-cost thin-layer chromatographic procedure in normal phase
system with densitometric detection at 246 nm was carefully validated according to the International
Conference on Harmonisation (ICH) guidelines for assay of clobetasol propionate in topical solution
containing clobetasol propionate in quantity 0.50 mg/mL. The adopted thin-layer chromatographic
(TLC)-densitometric procedure could effectively separate clobetasol propionate from its related
compound, namely clobetasol. It is linear for clobetasol propionate in the range of 0.188 ÷ 5 µg/spot.
The limit of detection (LOD) and limit of quantification (LOQ) value is 0.061 and 0.186 µg/spot,
respectively. Accuracy of proposed procedure was evaluated by recovery test. The mean recovery
of studied clobetasol propionate ranges from 98.7 to 101.0%. The coefficient of variation (CV, %)
obtained during intra-day and inter-day studies, which was less than 2% (0.40 ÷ 1.17%), confirms
the precision of described method. The assay value of clobetasol propionate is consistent with the
pharmacopoeial requirements. In conclusion, it can be suitable as a simple and economic procedure
for routine quality control laboratories of clobetasol propionate in topical solution.
Keywords: clobetasol; clobetasol propionate; topical steroids; TLC-densitometry; validation
1. Introduction
The corticosteroids are a group of chemical compounds which have potent immunosuppressive
and anti-inflammatory activity. Topical corticosteroids are widely used for the treatment of
various skin dermatoses associated with inflammation and pruritus [1–7]. Clobetasol 17-propionate
(21-chloro-9-fluoro-11β,17-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-propionate) is one
of the most potent topical corticosteroids [1]. It belongs to US class I of the corticosteroids,
namely superpotent corticosteroids [1]. Clobetasol propionate is commercially available in different
pharmaceutical formulations as ointment, cream, gel, lotion, spray, emollient cream, foam, solution for
skin and shampoo in amounts about 0.05% of total weight of the formulation [3]. It is used alone or
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in combination with other topical agents to treat different skin dermatoses such as chronic eczema,
atopic dermatoses, bullous autoimmune skin dermatoses and psoriasis [4–7]. Therefore, it is very
important to establish and validate as per the International Conference on Harmonisation Guidelines
(ICH) a simple and economical procedure for quantifying of clobetasol propionate in available
pharmaceutical formulations [8]. The method currently used for the determination of clobetasol
propionate is spectrophotometry and also RP-HPLC technique with various detection systems like for
instance spectrophotometry at UV light or mass spectrometry (HPLC-MS), respectively [9–21]. To the
best of our knowledge no much report could be found for the determination of clobetasol propionate in
pharmaceutical formulation using simple and economical thin-layer chromatographic (TLC) procedure.
A thorough literature review revealed that there are only few TLC methods for clobetasol propionate in
respective dosage forms (i.e., cream and lotion) [22–24]. Until now, there has been no report regarding
the use of the TLC-densitometric method for the quantification of clobetasol propionate in the form of
topical solution. What is more, there is no pharmacopoeial TLC-densitometric method described for
the assay of clobetasol propionate in drug formulation, including its topical solution.
Taking this consideration into account, in the present research work we propose a simple
TLC-densitometric procedure for estimation and determination of clobetasol propionate in form
of solution for skin (0.50 mg/mL). Established method has been carefully verified according to
ICH guidelines and compared with pharmacopoeial requirements for clobetasol propionate topical
solution [8,25,26]. The proposed TLC-densitometric procedure is simple to use and low-cost, thereby
it can widely be applied in routine analysis and quality control of clobetasol propionate in form of
topical solution.
The results obtained in this paper can confirm the suggestions set out in the current literature by
the authors of other works [27–29], that among various analytical methods, thin-layer chromatography
combined with densitometry due its simplicity and low cost is a good tool for separating, detecting
and quantifying different compounds including steroids, such as selected flavonoids, polyphenols,
β-carotene and food dyes in different matrices (i.e., in plant samples as well as synthetic pharmaceutical
preparations) [27–29].
2. Results and Discussion
2.1. Procedures
Optimization of Chromatographic Conditions
Based on the literature review, several chromatographic systems consisted of various
chromatographic plates for TLC precoated with silica gel 60F254 as well as silica gel RP-18F254 or
mixture of silica gel 60 and Kieselguhr F254 and different mobile phases such as acetonitrile-methanol,
chloroform-acetone-methanol, toluene-chloroform-methanol-ammonium and toluene-methanol in
different ratio have been tried in order to find the best developing system for the analysis of clobetasol
propionate in form of solution for skin [22–24]. Of all the chromatographic systems tested in
preliminary study, the most suitable was that consisted of chromatographic plates precoated with
conventional silica gel 60F254 as stationary phase and binary mixture of toluene-methanol (40:9.8 v/v)
as a mobile phase [22]. Separation was done on preactivated at 110 ◦C during 20 min TLC plates.
Solutions (5 µL) of clobetasol propionate and clobetasol, respectively, were spotted using Camag
micropipette onto applied TLC plates. TLC chamber was saturated with mobile phase for 20 min
before analysis. It was observed that saturation of TLC chamber with mobile phase for 20 min ensure
good reproducibility and peak shape of examined substances. The mobile phase was run up to
a distance of 7 cm, which takes about 15 min for complete development of the chromatographic plates.
The plates were left to dry, then spots were scanned at maximum wavelength (λ = 246 nm), see Figure 1.
An exemplary TLC densitogram of clobetasol propionate and related compound, namely clobetasol is
shown in Figure 2.
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The separation factors obtained on the basis of TLC densitograms using the Equations (1)–(4) 
for clobetasol propionate (CP) and its pharmaceutical impurity clobetasol (C) under mentioned 
chromatographic conditions as shown in Table 1 are satisfactory. Calculated ΔRF for separated pair 
of the two examined compounds CP and C is more than 0.05. Other separation factors, such as Rs, α 
and RF are above 1.00 (Table 1), thus indicate also good separation of CP from C. Hence, these 
optimum conditions were applied in subsequent work. 
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Figure 2. Two dimensions TLC chromatogram showing the separation of clobetasol propionate from
clobetasol at RF = 0.51 ± 0.01 and 0.45 ± 0.01, respectively.
The separation factors obtained on the basis of TLC densitograms using the Equations (1)–(4)
for clobetasol propionate (CP) and its pharmaceutical impurity clobetasol (C) under mentioned
chromatographic conditions as shown in Table 1 are satisfactory. Calculated ∆RF for separated pair of
the two examined compounds CP and C is more than 0.05. Other separation factors, such as Rs, α and
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RFα are above 1.00 (Table 1), thus indicate also good separation of CP from C. Hence, these optimum
conditions were applied in subsequent work.
∆RF(1,2) = RF2 − RF1 (1)
where RF—retardation factor of examined compounds, and RF2 > RF1.
RS =
2d
wb1 + wb2
(2)
where d—distance between the centers of two neighboring bands [mm]; wb—bands width at the base
line (mm).
α =
1
RF1
− 1
1
RF2
− 1 (3)
where RF1 < RF2.
RαF(1,2) =
RF1
RF2
(4)
where RF1 > RF2.
Table 1. Parameters of chromatographic separation of clobetasol propionate and clobetasol using
proposed TLC-densitometric method.
Parameter Results
∆RF 0.06
RS 1.25
α 1.27
RFα 1.13
Figure 3 performs three dimensions TLC chromatograms showing clobetasol, clobetasol
propionate and marketed formulation (0.05% topical solution) of clobetasol propionate, respectively.
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Figure 3. Three dimensions TLC chromatograms showing clobetasol, clobetasol propionate and
marketed formulation (0.05% topical solution) of clobetasol propionate, respectively. Notes: yellow
color—scanned background of TLC chromatogram; @—at.
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2.2. Validation Data
The results of validation studies of TLC-densitometric method adopted for the determination of
clobetasol propionate in form of solution for skin using toluene-methanol (40:9.8 v/v) as the mobile
phase on silica gel 60F254 plates with the detection at 246 nm are given below.
2.2.1. Specificity
The specificity of proposed chromatographic procedure was checked by analyzing standard
drug of clobetasol propionate and its marketed formulation (topical solution). The spot of clobetasol
propionate in examined topical solution was confirmed by comparing RF value and also UV-VIS spectra
of both samples. Good correlation between the standard and sample peaks measured at three different
regions of chromatographic bands, namely r(S,M) = 0.998 and r(M,E) = 0.994, where (S)—is peak start,
(M)—peak apex and (E)—is peak end confirms specificity of described method. TLC densitogram of
examined topical solution in Figure 4 shows that there is no excipients and additives (i.e., carbomer,
isopropyl alcohol, sodium hydroxide) interference with studied active ingredient, namely clobetasol
propionate present in topical solution. Therefore, the proposed procedure can be suitable in the
TLC-densitometric analysis of clobetasol propionate as topical solution.
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to quantify of clobetasol propionate in the more widely concentration range of th s compound in
Molecules 2017, 22, 1888 6 of 13
comparison with those dedicated for other pharmaceutical formulations like for example lotion or
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Figure 6. Calibration plot for clobetasol propionate (a) and plot of residuals (b) in linear working range.
The statistical characteristic of obtained calibration curve includes, the correlation coefficient,
slope, intercept and other are summarized in Table 2. As shown Table 2 the statistical data demonstrate
also strong linear relationship between variables. Correlation coefficient (r) > 0.995 fulfils the
ICH requirements needed for analytical procedures used in quantifying of active ingredients [8].
Comparison with other works [9–21] indicates that the use of HPLC technique allows to obtain much
better correlation coefficient (r ≥ 0.999) of calibration plots at lower or higher range of concentration of
clobetasol propionate, respectively in relation to that described in current paper [9–21].
Table 2. Linear model and statistical parameters of calibration curve y = a + bx.
Parameter Results
Wavelength (nm) 246
Linearity range (µg/spot) 0.188–5
Slope (b) 2858.18
Standard deviation of the slope (Sb) 87.84
Coefficient of variation (CV, %) of slope 3.08
Intercept (a) 1877.43
Standard deviation of the intercept (Sa) 226.36
Correlation coefficient (r) 0.998
Standard deviation of residuals (Sy/x) 385.19
F 1058.85
Significance level (p) 0
Limit of detection (LOD) in µg/spot 0.061
Limit of quantification (LOQ) in µg/spot 0.186
2.2.3. LOD and LOQ
The limits of detection (LOD) and quantification (LOQ) of suggested method were checked and
calculated on the basis of calibration plot prepared using the peak area measurements of examined
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clobetasol propionate at the lowest part of working range. The following Equations (5) and (6) were
applied in order to calculate the LOD and LOQ value, respectively.
LOD = 3.3 × σ/S (5)
LOQ = 10 × σ/S (6)
where σ—standard deviation of the response, S—slope of calibration plot. The LOD was found to be
0.061 µg/spot, while the LOQ was 0.186 µg/spot. Both results confirm good sensitivity which is enough
for the determination of clobetasol propionate in marketed formulation, especially in form of topical
solution containing 0.50 mg of studied compound as active ingredient per one mL of analyzed topical
solution. The LOD and LOQ level (given in µg/spot of clobetasol propionate), thus the sensitivity
of adopted TLC-densitometric procedure is comparable to that reported for clobetasol propionate
in form of cream by other authors [23]. Similar level of detection and quantitation (at micrograms)
can be observed also in the case of selected HPLC procedures recommended for assay of clobetasol
propionate in simple as well as complex pharmaceutical formulations, like for example in combination
with salicylic acid (LOD = 0.036 µg/mL, LOQ = 0.109 µg/mL) [18]. A very low LOQ (0.75 ÷ 3 ng/mL)
was achieved using the modern LC/MS/MS method for clobetasol propionate and other undeclared
steroids in cosmetic creams [19].
2.2.4. Accuracy
The method accuracy was determined by recovery studies and expressed as percent recovered,
see Table 3. This experiment was carried out by standard addition method at different levels of
clobetasol propionate in studied pharmaceutical formulation i.e., topical solution. Appropriate amount
of clobetasol propionate (standard powder) corresponding to 50%, 100% and 150% of label claim
had been added to the sample solution. The chromatograms were studied under the optimized
chromatographic conditions. Determination was performed in triplicate at each level. Table 3 complies
the results of recovery study. As is shown in Table 3, the mean value of recovery is placed in the
range of 98.7% ÷ 101.0% for 50%, 100% and 150% of clobetasol propionate added. The calculated
coefficient of variation (CV, %) ranges from 0.36 to 0.81, thus is less than 1%. The statistical results of
recovery study are under the acceptance range according to ICH guidelines [8]. Satisfactory recovery
of clobetasol propionate suggesting that there is no interference from any of excipients and additives
which are present in examined topical solution. Comparison of obtained results with mean recovery of
clobetasol propionate examined by proposed TLC-densitometric procedure with those obtained by
HPLC system in various topical formulations indicates that the HPLC method enables achieve very
similar recovery range of clobetasol propionate to the proposed TLC method. It is generally placed
from 95.1 to 100.0% for propionate clobetasol in complex preparation with everolimus [15], from 97.81
to 98.35% for clobetasol propionate which has been analyzed in topical nanocapsule suspension [9]
or from 100.03 to 100.05% for clobetasol propionate in its pharmaceutical preparation with salicylic
acid [18].
Table 3. Results of accuracy.
Nominal Amount
of Clobetasol
Propionate in
Drug (mg/mL)
Amountof Pure
Clobetasol
Propionate
Added (mg)
Total Amount of
Clobetasol Propionate
in Drug Sample
(mg/mL)
Average Amount of
Clobetasol Propionate
Found in Drug Sample
(mg/mL)
±SD CV (%) Recovery(%)
0.50 0.25 (50%) 0.75 0.74 0.006 0.81 98.7
0.50 0.50 (100%) 1.00 1.01 0.008 0.78 101.0
0.50 1.00 (150%) 1.50 1.49 0.005 0.36 99.3
SD = standard deviation; CV = coefficient of variation.
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2.2.5. Precision
The precision of the proposed TLC-densitometric procedure which demonstrates the ability
of an analytical method to produce consistent results was evaluated in terms of repeatability
(intra-day precision) and also intermediate precision (inter-day precision) by spotting onto applied TLC
chromatographic plates the sample of topical solution corresponding to 1.00, 1.50 and 2.00 µg/spot of
clobetasol propionate.
Repeatability of the adopted TLC-densitometric method was performed at three different times
on the same day. Inter-day variations were performed by analyzing same concentration of examined
clobetasol propionate in three different days over a period of a week and by two different analysts
and using two various batches of chromatographic plates. The precision of described method was
expressed in terms of coefficient of variation (CV, %). The results depicted in Table 4 revealed high
precision of supposed method. As shown Table 4, the mean value of recovery ranged from 98.7 to
101.5% in the case of intra-day precision. The % CV values are placed in the range between 0.49 and
0.94%, thus, less than 1%. Similarly, satisfactory results of high percent recovery of studied clobetasol
propionate in topical solution ranging from 98.0 to 99.3% can be observed for measured intermediate
precision (Table 4). The coefficient of variation is also good because it was found to be from 0.40 to
1.17%. Therefore, it can be suggested that the proposed TLC-densitometric method indicates relatively
high intra- and also inter-day precision which is in a good agreement with ICH requirements as well
as HPLC method [15,16].
Table 4. Results of method precision.
Intra-Day Precision (Repeatability, n = 3)
Amount of Clobetasol Propionate (µg/spot) Measured Amount± SD CV (%) Recovery (%)
1.00 1.01 ± 0.008 0.79 101.0
1.50 1.48 ± 0.014 0.94 98.7
2.00 2.03 ± 0.010 0.49 101.5
Intra-Day Precision (Intermediate Precision, n = 3)
Amount of Clobetasol Propionate (µg/spot) Measured Amount± SD CV (%) Recovery (%)
1.00 0.98 ± 0.009 0.92 98.0
1.50 1.49 ± 0.006 0.40 99.3
2.00 1.97 ± 0.023 1.17 98.5
SD = standard deviation; CV = coefficient of variation.
Summarizing the results of accuracy and precision described above, it can be concluded that
adopted method shows no significant differences in accuracy and precision when compared with
reported TLC methods [22,23]. Comparability of accuracy and precision results with those obtained
by selected HPLC procedures indicates that proposed TLC-densitometric method can be a good
alternative for assay of clobetasol propionate in its topical solution.
2.2.6. Robustness
Robustness of the proposed TLC-densitometric method was checked by evaluating the effect
of small changes of applied chromatographic conditions on the results, i.e., on the measured
peak area and also on the percent amount of clobetasol propionate in studied topical solution.
Introduction of the following small changes into TLC procedure such as the time required for
chamber saturation (±10 min), the volume of mobile phase used (±10 mL), development distance
(±10 mm), the temperature of activation of chromatographic plates (±10 ◦C) and the time from
spotting to chromatography (±10 min) was assessed. The robustness was determined at three different
concentration levels of clobetasol propionate: 1.00, 1.50 and also 2.00 µg/spot. As shown Table 5, the
percent assay of clobetasol propionate in examined topical solution under amended chromatographic
conditions, thus for each parameter is high and ranged from 101.3% ÷ 111.8%. The % CV of peak
area (found to be less than 2%). Taking into account the obtained results, it can be concluded that the
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adopted TLC-densitometric procedure was to be unaffected by small changes of chromatographic
conditions, thereby it is robust.
Table 5. Robustness of proposed TLC-densitometric method (n = 3).
Method Parameters CV (%) of Peak Area Assay of Clobetasol Propionate (%)
Chamber saturation time (±10 min) 0.75 101.5
Volume of mobile phase (varied ±10 mL) 1.48 111.8
Development distance (±10 mm) 1.31 109.1
Temperature of activation of chromatographic plates (±10 ◦C) 0.87 101.3
Time from spotting to chromatography (±10 min) 0.97 104.8
CV = coefficient of variation.
2.2.7. Analysis of Formulation (Topical Solution)
The accurately validated TLC-procedure in combination with densitometry was applied
for determination of clobetasol propionate in commercially available topical solution containing
clobetasol propionate in base at a quantity 0.50 mg/mL and others like carbomer, isopropyl alcohol,
sodium hydroxide and purified water as excipients and additives, respectively. Development and
quantification was performed under the mentioned chromatographic conditions. The results of assay
were listed in Table 6.
Table 6. Assay of clobetasol propionate by proposed TLC-densitometric method in topical solution.
Parameter Data
Number of determinations 6
The label claim of clobetasol propionate in (mg/mL) 0.50
Average amount of clobetasol propionate (mg/mL) 0.49
Minimum amount of clobetasol propionate (mg/mL) 0.47
Maximum amount of clobetasol propionate (mg/mL) 0.51
Standard deviation (SD) 0.008
Coefficient of variation (CV, %) 1.63
Confidence interval of arithmetic mean with confidence level equal 95% (mg/mL) 0.49 ± 0.02
Amount of clobetasol propionate (%) in relation to the label claim 98.0%
The average content of six determinations was found to be 0.49 ± 0.02 mg/mL and represent
98.0% in relation to the label claim. The coefficient of variation (CV, %) is less than 2%. The results
of the amount of clobetasol propionate in studied topical solution fulfil the ICH guidelines and also
pharmacopoeial requirements [8,25,26]. According to USP monographs the clobetasol propionate
topical solution should contain not less than 90.0% and not more than 110% of labeled amount of
clobetasol propionate [26]. Good compliance of the amount of clobetasol propionate found in examined
marketed formulation in form of topical solution with labeled claim as well as pharmacopoeial
requirements suggesting that there is no interference from any of the excipients and additives which
are normally present in clobetasol propionate topical solution, i.e., carbomer, isopropyl alcohol and
sodium hydroxide. Thereby, the proposed TLC-procedure can be successfully applied for routine
quality control of clobetasol propionate in form of marketed available topical solution. For comparison,
the determination of clobetasol propionate in drug samples by means of HPLC method showed
the results of clobetasol propionate according to the theoretical value, for example, in the range of
99.95% ÷ 102.27% or 100.71% for ointment dosage form [15,16].
3. Experimental Section
3.1. Apparatus
TLC densitometer: A Camag TLC Scanner 3 (Camag, Muttenz, Switzerland) in the reflectance
absorbance mode operated by WinCATS software. The source of radiation was a deuterium and
tangsten lamp respectively. The chromatographic plates were scanned with slit dimension of
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8.00 mm × 0.40 mm and scanning speed of 20 mm/s. Data resolution was 100 µm/step. Spectrum
scan speed was kept at 100 nm/s.
3.2. Chemicals and Solvents
The solvents, methanol, toluene used in current study were procured from POCh (Gliwice,
Poland). Both solvents were of HPLC grade. Standard clobetasol (purity ≥ 99.5%, pharmaceutical
impurity standard) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Reference standard
clobetasol propionate (Sigma-Aldrich) was pharmaceutical-grade substance and fulfils the
requirements of USP Pharmacopoeia [26].
3.3. Pharmaceutical Preparation
Clobetasol propionate in form of solution for skin (bottle 50 mL) was purchased from commercial
source (local market, Poland). 0.05% solution contains the active compound clobetasol propionate in
quantity 0.50 mg/mL and the following excipients as well as additives: carbomer, isopropyl alcohol,
sodium hydroxide and purified water.
3.4. Materials
Chromatography was performed on precoated silica gel 60F254 plates (20 cm × 20 cm, Merck,
Darmstadt, Germany, Art. 1.05554), which were cut into 10 cm × 10 cm before use. The solutions
were spotted onto chromatographic plates using 5 µL micropipettes (Camag, Muttenz, Switzerland).
Ascending development was performed in a Camag twin-trough chamber (20 cm × 10 cm).
3.5. Preparation of Standard Stock Solutions
Standard stock solutions with a concentration of 1 mg/mL were prepared in methanol for
clobetasol propionate and clobetasol, respectively. From the standard stock solution, different diluted
solutions of clobetasol propionate were prepared. The stock solution was stored at 2–8 ◦C. The solution
(5 µL) was spotted on the TLC plate in each case.
3.6. Sample Preparation
Examined topical solution (5 mL, 0.50 mg/mL) was carefully transferred into 10 mL
volumetric flask, then diluted to 10 mL with methanol, and then shaken vigorously and filtered.
The resulting solution at final concentration of clobetasol propionate of 0.25 mg/mL was spotted
on TLC plates in quantity 5 µL. Development and quantification was performed under adopted
chromatographic conditions.
4. Conclusions
A simple, accurate, precise, specific and robust TLC-densitometric procedure was suggested to
quantify clobetasol propionate in marketed formulation in the form of a topical solution. The reported
method met all ICH validation acceptance criteria. Experimental results showed that the amount of
propionate clobetasol in examined pharmaceutical formulation expressed as a percentage of label
claim was in good agreement with pharmacopoeial requirements for clobetasol propionate topical
solution. The main advantage of supposed procedure is low cost in relation to reported HPLC
method and minimum sample preparation resulting in relatively short time of analysis in comparison
with TLC-densitometric and spectrophotometric procedures described for other pharmaceutical
formulations such as lotion or cream, respectively. In addition to this, the validated method covers
a wide range of linearity. The method showed no significant difference in accuracy and precision when
compared with other reported TLC methods as well as selected HPLC procedures regarding lotion and
cream analysis. The LOD and LOQ demonstrate that the sensitivity of suggested TLC-densitometric
procedure is much less in relation to the modern HPLC/MS/MS systems but is enough for the purpose
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of routine quality control of clobetasol propionate in topical solution. The proposed TLC-densitometric
procedure can be a substitute for the reported HPLC method when HPLC is not available.
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